vs

Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $43.2M, roughly 1.2× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -71.6%, a 195.5% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs -11.8%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-24.9M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

ADAM vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.2× larger
MRVI
$49.9M
$43.2M
ADAM
Growing faster (revenue YoY)
ADAM
ADAM
+73.5% gap
ADAM
61.6%
-11.8%
MRVI
Higher net margin
ADAM
ADAM
195.5% more per $
ADAM
124.0%
-71.6%
MRVI
More free cash flow
ADAM
ADAM
$150.8M more FCF
ADAM
$125.9M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
ADAM
ADAM
Annualised
ADAM
55.5%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADAM
ADAM
MRVI
MRVI
Revenue
$43.2M
$49.9M
Net Profit
$53.5M
$-35.7M
Gross Margin
25.8%
Operating Margin
-117.9%
Net Margin
124.0%
-71.6%
Revenue YoY
61.6%
-11.8%
Net Profit YoY
270.5%
-37.7%
EPS (diluted)
$0.45
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADAM
ADAM
MRVI
MRVI
Q4 25
$43.2M
$49.9M
Q3 25
$36.6M
$41.6M
Q2 25
$36.4M
$47.4M
Q1 25
$33.1M
$46.9M
Q4 24
$26.7M
$56.6M
Q3 24
$20.2M
$69.0M
Q2 24
$19.0M
$69.4M
Q1 24
$17.9M
$64.2M
Net Profit
ADAM
ADAM
MRVI
MRVI
Q4 25
$53.5M
$-35.7M
Q3 25
$44.8M
$-25.6M
Q2 25
$8.5M
$-39.6M
Q1 25
$42.2M
$-29.9M
Q4 24
$-31.4M
$-25.9M
Q3 24
$42.8M
$-97.1M
Q2 24
$-15.6M
$-9.8M
Q1 24
$-57.9M
$-12.1M
Gross Margin
ADAM
ADAM
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
ADAM
ADAM
MRVI
MRVI
Q4 25
-117.9%
Q3 25
-98.6%
Q2 25
11.7%
-139.8%
Q1 25
-104.9%
Q4 24
-119.0%
-66.7%
Q3 24
-239.9%
Q2 24
-124.7%
-19.4%
Q1 24
-448.8%
-29.4%
Net Margin
ADAM
ADAM
MRVI
MRVI
Q4 25
124.0%
-71.6%
Q3 25
122.5%
-61.4%
Q2 25
23.4%
-83.5%
Q1 25
127.4%
-63.9%
Q4 24
-117.5%
-45.8%
Q3 24
211.7%
-140.6%
Q2 24
-81.9%
-14.1%
Q1 24
-324.1%
-18.8%
EPS (diluted)
ADAM
ADAM
MRVI
MRVI
Q4 25
$0.45
$-0.24
Q3 25
$0.36
$-0.18
Q2 25
$-0.04
$-0.27
Q1 25
$0.33
$-0.21
Q4 24
$-0.46
$-0.21
Q3 24
$0.36
$-0.68
Q2 24
$-0.29
$-0.07
Q1 24
$-0.75
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADAM
ADAM
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$210.3M
$216.9M
Total DebtLower is stronger
$735.8M
$291.8M
Stockholders' EquityBook value
$1.4B
$212.4M
Total Assets
$12.6B
$770.6M
Debt / EquityLower = less leverage
0.52×
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADAM
ADAM
MRVI
MRVI
Q4 25
$210.3M
$216.9M
Q3 25
$185.3M
$243.6M
Q2 25
$160.4M
$269.9M
Q1 25
$177.1M
$285.1M
Q4 24
$167.4M
$322.4M
Q3 24
$195.1M
$578.2M
Q2 24
$235.5M
$573.2M
Q1 24
$226.9M
$561.7M
Total Debt
ADAM
ADAM
MRVI
MRVI
Q4 25
$735.8M
$291.8M
Q3 25
$766.6M
$292.8M
Q2 25
$653.0M
$293.9M
Q1 25
$654.4M
$294.9M
Q4 24
$573.2M
$295.9M
Q3 24
$699.4M
$521.7M
Q2 24
$800.7M
$522.5M
Q1 24
$1.0B
$523.3M
Stockholders' Equity
ADAM
ADAM
MRVI
MRVI
Q4 25
$1.4B
$212.4M
Q3 25
$1.4B
$245.4M
Q2 25
$1.4B
$265.9M
Q1 25
$1.4B
$300.6M
Q4 24
$1.4B
$325.3M
Q3 24
$1.4B
$344.9M
Q2 24
$1.4B
$434.7M
Q1 24
$1.5B
$410.7M
Total Assets
ADAM
ADAM
MRVI
MRVI
Q4 25
$12.6B
$770.6M
Q3 25
$12.4B
$849.2M
Q2 25
$10.6B
$897.0M
Q1 25
$10.0B
$959.8M
Q4 24
$9.2B
$1.0B
Q3 24
$8.9B
$1.3B
Q2 24
$8.2B
$1.4B
Q1 24
$7.4B
$1.4B
Debt / Equity
ADAM
ADAM
MRVI
MRVI
Q4 25
0.52×
1.37×
Q3 25
0.55×
1.19×
Q2 25
0.47×
1.11×
Q1 25
0.47×
0.98×
Q4 24
0.41×
0.91×
Q3 24
0.48×
1.51×
Q2 24
0.56×
1.20×
Q1 24
0.67×
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADAM
ADAM
MRVI
MRVI
Operating Cash FlowLast quarter
$134.0M
$-22.8M
Free Cash FlowOCF − Capex
$125.9M
$-24.9M
FCF MarginFCF / Revenue
291.6%
-49.9%
Capex IntensityCapex / Revenue
18.9%
4.2%
Cash ConversionOCF / Net Profit
2.50×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADAM
ADAM
MRVI
MRVI
Q4 25
$134.0M
$-22.8M
Q3 25
$6.9M
$-15.2M
Q2 25
$39.2M
$-10.3M
Q1 25
$25.8M
$-9.4M
Q4 24
$14.1M
$-14.6M
Q3 24
$-922.0K
$13.1M
Q2 24
$-993.0K
$17.4M
Q1 24
$-13.1M
$-8.5M
Free Cash Flow
ADAM
ADAM
MRVI
MRVI
Q4 25
$125.9M
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-10.6M
$-20.5M
Q3 24
$-8.6M
$4.5M
Q2 24
$-8.6M
$7.9M
Q1 24
$-19.1M
$-14.1M
FCF Margin
ADAM
ADAM
MRVI
MRVI
Q4 25
291.6%
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-39.6%
-36.2%
Q3 24
-42.3%
6.6%
Q2 24
-44.9%
11.4%
Q1 24
-107.0%
-22.0%
Capex Intensity
ADAM
ADAM
MRVI
MRVI
Q4 25
18.9%
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
92.3%
10.3%
Q3 24
37.7%
12.4%
Q2 24
39.7%
13.8%
Q1 24
33.5%
8.8%
Cash Conversion
ADAM
ADAM
MRVI
MRVI
Q4 25
2.50×
Q3 25
0.15×
Q2 25
4.59×
Q1 25
0.61×
Q4 24
Q3 24
-0.02×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADAM
ADAM

Other$19.6M45%
Constructive Loans LLC$14.4M33%
Multifamily$9.1M21%

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons